Non-proportionality of hazards in the competing risks framework

Lecture Notes in Statistics

Volumn 215, Issue , 2013, Pages 3-22

  Muñoz, Alvaro ^a   Abraham, Alison G ^a   Matheson, Matthew ^a   Wada, Nikolas ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORECASTING; RISK ASSESSMENT; SOFTWARE TESTING;

ANALYTICAL APPROACH; COMPETING RISKS; CUMULATIVE INCIDENCE; NONPROPORTIONALITY; RELATIVE HAZARDS; SEPARATE ANALYSIS; STATISTICAL POWER; STATISTICAL SIGNIFICANCE;

HAZARDS;

EID: 84945942078     PISSN: 09300325     EISSN: 21977186     Source Type: Conference Proceeding    
DOI: 10.1007/978-1-4614-8981-8_1     Document Type: Conference Paper

References (32)

1. Putter, H., Fiocco, M., Geskus, R.B.: Tutorial in biostatistics: competing risks and multi-state models. Stat. Med. 26, 2389–2430 (2007). doi:10.1002/sim.2712
2. Cox, D.R., Oakes, D.: The Analysis of Survival Data, pp. 142–155. Chapman & Hall, New York (1984)
3. Gaynor, J.J., Feurer, E.J., Tan, C., Wu, D.H., Little, C.R., Straus, D.J., Clarkson, B.D., Brennan, M.F.: On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J. Am. Stat. Assoc. 88, 400–409 (1993). doi:10.1080/01621459.1993.10476289
4. Holt, J.D.: Competing risk analyses with special reference to matched pair experiments. Biometrika 65, 159–165 (1978). doi:10.1093/biomet/65.1.159
5. Kalbfleisch, J.D., Prentice, R.L.: The Statistical Analysis of Failure Time Data. Wiley, New York (1980)
6. Larson, M.G.: Covariate analysis of competing-risks data with log-linear models. Biometrics 40, 459–469 (1984)
7. Prentice, R.L., Kalbfleisch, J.D., Peterson Jr., A.V., Flournoy, N., Farewell, V.T., Breslow, N.E.: The analysis of failure times in the presence of competing risks. Biometrics 34, 541–554 (1978)
8. Fine, J.P., Gray, R.J.: A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496–509 (1999). doi:10.1080/01621459.1999.10474144
9. Gray, R.J.: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 16, 1141–1154 (1988). doi:10.1214/aos/1176350951
10. Pepe, M.S.: Inference for events with dependent risks in multiple endpoint studies. J. Am. Stat. Assoc. 86, 770–778 (1991). doi:10.1080/01621459.1991.10475108
11. Beyersmann, J., Allignol, A., Schumacher, M.: Competing risks and multistate models with R, pp. 89–153. Springer, New York (2012)
12. Babiker, A., Darbyshire, J., Pezzotti, P., Porter, K., Rezza, G., Walker, S.A., et al.: Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int. J. Epidemiol. 31, 951–958 (2002). doi:10.1093/ije/31.5.951
13. del Amo, J., Perez-Hoyos, S., Moreno, A., Quintana, M., Ruiz, I., Cisneros, J.M., Ferreros, I., Gonzalez, C., de Olalla, P.G., Perez, R., Hernandez, I.: Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease. J. Acquir. Immune Defic. Syndr. 41, 624–631 (2006). doi:10.1097/01.qai.0000194232.85336.dc
14. Lim, H.J., Zhang, X., Dyck, R., Osgood, N.: Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes. BMC Med. Res. Methodol. 10, 97 (2010). doi:10.1186/1471-2288-10-97
15. Pacheco, A.G., Tuboi, S.H., May, S.B., Moreira, L.F.S., Ramadas, L., Nunes, E.P., Merçon, M., Faulhaber, J.C., Harrison, L.H., Schechter, M.: Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. J. Acquir. Immune Defic. Syndr. 51, 624–630 (2009). doi:10.1097/QAI.0b013e3181a4ecf5
16. Wada, N., Jacobson, L.P., Cohen, M., French, A.L., Phair, J., Muñoz, A.: Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies: 1984–2008. Am. J. Epidemiol. 15, 116–125 (2013). doi:10.1093/aje/kws321
17. Checkley, W., Brower, R.G., Muñoz, A.: Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology 21, 557–565 (2010). doi:10.1097/EDE.0b013e3181e090ed
18. Cole, S.R., Li, R., Anastos, K., Detels, R., Young, M., Chmiel, J.S., Muñoz, A.: Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies. Stat. Med. 23, 3351–3363 (2004). doi:10.1002/sim.1579
19. Larson, M.G., Dinse, G.E.: A mixture model for the regression analysis of competing risks data. J. R. Stat. Soc. Ser. C (Appl. Stat.) 34, 201–211 (1985). doi:10.2307/2347464
20. Beyersmann, J., Latouche, A., Buchholz, A., Schumacher, M.: Simulating competing risks data in survival analysis. Stat. Med. 28, 956–971 (2009). doi:10.1002/sim.3516
21. Latouche, A., Boisson, V., Chevret, S., Porcher, R.: Misspecified regression model for the subdistribution hazard of a competing risk. Stat. Med. 26, 965–974 (2007). doi:10.1002/sim.2600
22. Zhang, X., Zhang, M.J., Fine, J.: A proportional hazard regression model for the subdistribution with right-censored and left-truncated competing risks data. Stat. Med. 30, 1933–1951 (2011). doi:10.1002/sim.4264
23. Furth, S.L., Cole, S.R., Moxey-Mims, M., Kaskel, F., Mak, R., Schwartz, G., Wong, C., Muñoz, A., Warady, B.A.: Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study clinical. J. Am. Soc. Nephrol. 1, 1006–1015 (2006). doi:10.2215/CJN.01941205
24. Geskus, R.B.: Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring. Biometrics 67, 39–49 (2011). doi:10.1111/j.1541-0420.2010.01420.x
25. Jeong, J.-H., Fine, J.P.: Parametric regression on cumulative incidence function. Biostatistics 8, 184–196 (2007). doi:10.1093/biostatistics/kxj040
26. del Amo, J., Jarring, I., May, M., Dabis, F., Crane, H., Podzamczer, D., et al.: Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe and the United States. Clin. Infect. Dis. 54, 1800–1809 (2013). doi:10.1093/cid/cit111
27. Klein, J.P.: Modelling competing risks in cancer studies. Stat. Med. 25, 1015–1034 (2006). doi:10.1002/sim.2246
28. Zhang, M.J., Fine, J.: Summarizing differences in cumulative incidence functions. Stat. Med. 27, 4939–4949 (2008). doi:10.1002/sim.3339
29. Chang, W.-H., Wang, W.: Regression analysis for cumulative incidence probability under competing risks. Statistica Sinica 19, 391–408 (2009)
30. Fine, J.P.: Analysing competing risks data with transformation models. J. R. Stat. Soc. Ser. B 61, 817–830 (1999). doi:10.1111/1467-9868.00204
31. Grambauer, N., Schumacher, M., Beyersmann, J.: Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified. Stat. Med. 29, 875–884 (2010). doi:10.1002/sim.3786
32. Lau, B., Cole, S.R., Gange, S.J.: Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry. Stat. Med. 30, 654–665 (2011). doi:10.1002/sim.4123 [correction in Statistics in Medicine 2012;31:1777–8. doi: 10.1002/sim.4468]